These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C AND Clinical Outcome
13 results:

  • 1. Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome.
    Pastore F; Gittinger H; Raab S; Tschuri S; Ksienzyk B; Konstandin NP; Schneider S; Rothenberg-Thurley M; Horny HP; Werner M; Sauerland MC; Amler S; Görlich D; Berdel WE; Wörmann B; Braess J; Hiddemann W; Tischer J; Herold T; Metzeler KH; Spiekermann K
    Br J Haematol; 2023 Sep; 202(6):1165-1177. PubMed ID: 37455345
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2A rearrangements.
    Yuen KY; Liu Y; Zhou YZ; Wang Y; Zhou DH; Fang JP; Xu LH
    Cancer Med; 2023 Jan; 12(2):1418-1430. PubMed ID: 35833755
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of ptpn11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia.
    Stasik S; Eckardt JN; Kramer M; Röllig C; Krämer A; Scholl S; Hochhaus A; Crysandt M; Brümmendorf TH; Naumann R; Steffen B; Kunzmann V; Einsele H; Schaich M; Burchert A; Neubauer A; Schäfer-Eckart K; Schliemann C; Krause S; Herbst R; Hänel M; Frickhofen N; Noppeney R; Kaiser U; Baldus CD; Kaufmann M; Rácil Z; Platzbecker U; Berdel WE; Mayer J; Serve H; Müller-Tidow C; Ehninger G; Bornhäuser M; Schetelig J; Middeke JM; Thiede C;
    Blood Adv; 2021 Sep; 5(17):3279-3289. PubMed ID: 34459887
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/
    Bill M; Mrózek K; Kohlschmidt J; Eisfeld AK; Walker CJ; Nicolet D; Papaioannou D; Blachly JS; Orwick S; Carroll AJ; Kolitz JE; Powell BL; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26340-26346. PubMed ID: 33020282
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Impact of Tyrosine Kinase Inhibitors on Chronic Myeloid leukemia Stem Cells and the Implication in Discontinuation.
    Jiang L; Wang H; Zhu X; Liu W; Zhou S; Geng Z; Xiao Y; Zou P; You Y; Li Q; Zhu X
    Stem Cells Dev; 2019 Nov; 28(22):1480-1485. PubMed ID: 31530245
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.
    Lipka DB; Witte T; Toth R; Yang J; Wiesenfarth M; Nöllke P; Fischer A; Brocks D; Gu Z; Park J; Strahm B; Wlodarski M; Yoshimi A; Claus R; Lübbert M; Busch H; Boerries M; Hartmann M; Schönung M; Kilik U; Langstein J; Wierzbinska JA; Pabst C; Garg S; Catalá A; De Moerloose B; Dworzak M; Hasle H; Locatelli F; Masetti R; Schmugge M; Smith O; Stary J; Ussowicz M; van den Heuvel-Eibrink MM; Assenov Y; Schlesner M; Niemeyer C; Flotho C; Plass C
    Nat Commun; 2017 Dec; 8(1):2126. PubMed ID: 29259247
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia.
    de Smith AJ; Ojha J; Francis SS; Sanders E; Endicott AA; Hansen HM; Smirnov I; Termuhlen AM; Walsh KM; Metayer C; Wiemels JL
    Oncotarget; 2016 Nov; 7(45):72733-72745. PubMed ID: 27683039
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.
    Sakaguchi H; Okuno Y; Muramatsu H; Yoshida K; Shiraishi Y; Takahashi M; Kon A; Sanada M; Chiba K; Tanaka H; Makishima H; Wang X; Xu Y; Doisaki S; Hama A; Nakanishi K; Takahashi Y; Yoshida N; Maciejewski JP; Miyano S; Ogawa S; Kojima S
    Nat Genet; 2013 Aug; 45(8):937-41. PubMed ID: 23832011
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia.
    Cheng CL; Hou HA; Lee MC; Liu CY; Jhuang JY; Lai YJ; Lin CW; Chen HY; Liu FT; Chou WC; Chen CY; Tang JL; Yao M; Huang SY; Ko BS; Wu SJ; Tsay W; Tien HF
    Blood; 2013 Apr; 121(16):3172-80. PubMed ID: 23449638
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia.
    Balgobind BV; Hollink IH; Arentsen-Peters ST; Zimmermann M; Harbott J; Beverloo HB; von Bergh AR; Cloos J; Kaspers GJ; de Haas V; Zemanova Z; Stary J; Cayuela JM; Baruchel A; Creutzig U; Reinhardt D; Pieters R; Zwaan CM; van den Heuvel-Eibrink MM
    Haematologica; 2011 Oct; 96(10):1478-87. PubMed ID: 21791472
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia.
    Pollard JA; Alonzo TA; Gerbing RB; Woods WG; Lange BJ; Sweetser DA; Radich JP; Bernstein ID; Meshinchi S
    Blood; 2006 Oct; 108(8):2764-9. PubMed ID: 16809615
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ptpn11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group.
    Loh ML; Reynolds MG; Vattikuti S; Gerbing RB; Alonzo TA; Carlson E; Cheng JW; Lee CM; Lange BJ; Meshinchi S;
    Leukemia; 2004 Nov; 18(11):1831-4. PubMed ID: 15385933
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Autografting with Ph-negative progenitors in patients at diagnosis of chronic myeloid leukemia induces a prolonged prevalence of Ph-negative hemopoiesis.
    Podestà M; Piaggio G; Sessarego M; Pitto A; Figari O; Soracco M; Carella AM; Dejana A; Rosti V; Fugazza G; Ravera G; Lerma E; Cazzola M; Bacigalupo A; Frassoni F
    Exp Hematol; 2000 Feb; 28(2):210-5. PubMed ID: 10706077
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.